AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 123 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,452,000 | -62.2% | 24,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $3,840,000 | -66.0% | 24,000 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $11,280,000 | -17.5% | 24,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $13,680,000 | -65.7% | 24,000 | 0.0% | 0.00% | -70.0% |
| Q3 2021 | $39,840,000 | -1.8% | 24,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $40,560,000 | -8.6% | 24,000 | 0.0% | 0.01% | -9.1% |
| Q1 2021 | $44,400,000 | +16.4% | 24,000 | 0.0% | 0.01% | +10.0% |
| Q4 2020 | $38,160,000 | +66.1% | 24,000 | 0.0% | 0.01% | +42.9% |
| Q3 2020 | $22,968,000 | +50.3% | 24,000 | 0.0% | 0.01% | +40.0% |
| Q2 2020 | $15,286,000 | +20.2% | 24,000 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $12,720,000 | -24.4% | 24,000 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $16,824,000 | – | 24,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cypress Capital Management LLC (WY) | 234,225 | $132,000 | 0.18% |
| Noven Financial Group, Inc. | 123,772 | $70,000 | 0.04% |
| Harvest Investment Services, LLC | 109,443 | $60,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 559,489 | $314,000 | 0.03% |
| COURIER CAPITAL LLC | 354,973 | $199,000 | 0.03% |
| Valeo Financial Advisors, LLC | 330,000 | $185,000 | 0.02% |
| Transform Wealth, LLC | 205,481 | $115,000 | 0.02% |
| WEDBUSH SECURITIES INC | 326,793 | $184,000 | 0.02% |
| STEEL GROVE CAPITAL ADVISORS, LLC | 55,500 | $31,000 | 0.02% |
| MONTAG A & ASSOCIATES INC | 230,000 | $129,000 | 0.01% |